See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.8B | n/a | n/a | |
| $8.6B | 7.0x | 20.0x | |
| $2.0B | 7.2x | -15.0x | |
| $1.8B | 8.6x | -36.3x | |
| $1.0B | n/a | n/a | |
| $347M | 7010.9x | -10.4x | |
| $288M | n/a | n/a | |
| $166M | 9.2x | 12.0x | |
| $53.5M | 19.0x | -3.1x | |
| $44.3M | 2.5x | 13.5x | |
| $41.8M | n/a | n/a | |
| $24.6M | 10.5x | -5.1x | |
| $22.8M | 24.6x | -6.6x | |
| $4.1M | n/a | n/a | |
| -$11.5M | -0.4x | n/a | |
| -$34.7M | n/a | 0.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics